首页> 外文期刊>American Journal of Pathology: Official Publication of the American Association of Pathologists >Downstream targets of homeobox gene HLX show altered expression in human idiopathic fetal growth restriction.
【24h】

Downstream targets of homeobox gene HLX show altered expression in human idiopathic fetal growth restriction.

机译:同源异型框基因HLX的下游目标显示人类特发性胎儿生长受限中表达的改变。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Fetal growth restriction (FGR), a clinically significant pregnancy disorder, is poorly understood at the molecular level. This study investigates idiopathic FGR associated with placental insufficiency. Previously, we showed that the homeobox gene HLX is expressed in placental trophoblast cells and that HLX expression is significantly decreased in human idiopathic FGR. Here, we used the novel approach of identifying downstream targets of HLX in cell culture to detect potentially important genes involved in idiopathic FGR. Downstream targets were revealed by decreasing HLX expression in cultured trophoblast cells with HLX-specific small interfering RNAs to model human idiopathic FGR and comparing these levels with controls using a real-time PCR-based gene profiling system. Changes in candidate HLX target mRNA levels were verified in an independent trophoblast cell line, and candidate target gene expression was assessed in human idiopathic FGR-affected placentae (n = 25) compared with gestation-matched controls (n = 25). The downstream targets RB1 and MYC, cell cycle regulatory genes, showed significantly increased mRNA levels in FGR-affected tissues compared with gestation-matched controls, whereas CCNB1, ELK1, JUN, and CDKN1 showed significantly decreased mRNA levels (n = 25, P < 0.001, t-test). The changes for RB1 and CDKN1C were verified by Western blot analysis in FGR-affected placentae compared with gestation-matched controls (n = 6). We conclude that cell cycle regulatory genes RB1, MYC, CCNB1, ELK1, JUN, and CDKN1C, which control important trophoblast cell functions, are targets of HLX.
机译:胎儿生长受限(FGR),一种临床上重要的妊娠疾病,在分子水平上了解甚少。这项研究调查与胎盘功能不全相关的特发性FGR。以前,我们表明同源盒基因HLX在胎盘滋养细胞中表达,并且在人类特发性FGR中HLX表达显着降低。在这里,我们使用了新颖的方法来鉴定细胞培养物中HLX的下游靶标,以检测参与特发性FGR的潜在重要基因。通过降低培养的滋养层细胞中含有HLX特异性小干扰RNA的HLX表达来模拟人特发性FGR,并使用基于实时PCR的基因谱分析系统将这些水平与对照进行比较,揭示了下游靶标。在独立的滋养层细胞系中验证了候选HLX目标mRNA水平的变化,并与妊娠匹配对照(n = 25)相比,在人类特发性FGR感染的胎盘(n = 25)中评估了候选目标基因的表达。与妊娠匹配对照相比,下游靶标RB1和MYC是细胞周期调控基因,在受FGR影响的组织中显示出显着增加的mRNA水平,而CCNB1,ELK1,JUN和CDKN1显示出显着降低的mRNA水平(n = 25,P < 0.001,t检验)。 RB1和CDKN1C的变化已通过Western blot分析在FGR感染的胎盘中与妊娠匹配的对照组进行了比较(n = 6)。我们得出结论,控制重要滋养细胞功能的细胞周期调控基因RB1,MYC,CCNB1,ELK1,JUN和CDKN1C是HLX的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号